At Amplion we have a commercial interest in access to high quality clinical information that can inform and contribute to our flagship product, BiomarkerBase. However, we are truly passionate about contributing to higher quality, more personalized, medical...
At Amplion, we see biomarkers as the key to delivering on the promise of personalized medicine. From drug research and discovery and companion diagnostic development to patient care, we understand that biomarkers will drive personalized care. Health Decisions CRO+...
This week’s Chart of the Week is an interesting one. We will most likely have a follow up after further analysis of the data from BiomarkerBase. Basically, the chart shows the total commercial usage of a biomarker by company count since the biomarkers first...
We are interested in how biomarkers are used in all aspects of healthcare. Today Amplion is focused on the supporting the research side of healthcare with our product BiomarkerBase, helping diagnostic, pharma and life science companies make strategic decisions...
In our Charts of the Week over the last several weeks we have been analyzing the use of unique biomarkers by pharmaceutical companies. We are extending that analysis today with a look at the biomarker discovery activity of pharma companies as compared with the number...